Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one MeSH Supplementary Concept Data 2025


MeSH Supplementary
7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one
Unique ID
C502972
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C502972
Entry Term(s)
COMPOUND A-CHPDPOO
KINK-1 compound
Registry Numbers
0
Heading Mapped to
*Oxazines
*Pyridines
Frequency
9
Note
inhibits IKK-beta kinase; structure in first source
Source
Br J Pharmacol 2005 May;145(2):178-92
Date of Entry
2005/08/21
Revision Date
2010/04/15
7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one Preferred
page delivered in 0.005s